Postoperative outcome after coronary artery bypass grafting in chronic obstructive pulmonary disease

Canadian Respiratory Journal

Volumn 14, Issue 1, 2007, Pages 19-24

  Manganas, Hélène ^a   Lacasse, Yves ^a   Bourgeois, Stéphanie ^a   Perron, Jean ^a   Dagenais, François ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

COPD; Coronary artery bypass; Heart surgery; Postoperative complications

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IPRATROPIUM BROMIDE; LONG ACTING DRUG; NITRATE; SHORT ACTING DRUG; THEOPHYLLINE; TIOTROPIUM BROMIDE;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BRONCHITIS; CARDIOGENIC SHOCK; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FATALITY; FEMALE; FORCED EXPIRATORY VOLUME; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; INCIDENCE; LENGTH OF STAY; LUNG EMBOLISM; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING; SPIROMETRY; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; WOUND DEHISCENCE; AGED; ARTIFICIAL VENTILATION; CASE CONTROL STUDY; HEART ARREST; HEART BLOCK; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; INTENSIVE CARE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SURVIVAL RATE; VITAL CAPACITY;

AGED; ATRIAL FIBRILLATION; BRONCHITIS; CASE-CONTROL STUDIES; CORONARY ARTERY BYPASS; FEMALE; FORCED EXPIRATORY VOLUME; HEART ARREST; HEART BLOCK; HUMANS; INCIDENCE; INTENSIVE CARE; LENGTH OF STAY; MALE; MIDDLE AGED; PLEURAL EFFUSION; PNEUMONIA; PNEUMOTHORAX; POSTOPERATIVE PERIOD; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SPIROMETRY; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION; VITAL CAPACITY;

EID: 34047259310     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/378963     Document Type: Article

References (30)

1. Grover FL, Hammermeister KE, Burchfiel C. Initial report of the Veterans Administration Preoperative Risk Assessment Study for Cardiac Surgery. Ann Thorac Surg 1990;50:12-26.
2. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. JAMA 1992;267:2344-8.
3. Grover FL, Johnson RR, Marshall G, Hammermeister KE. Factors predictive of operative mortality among coronary artery bypass subsets. Ann Thorac Surg 1993;56:1296-306.
4. Durand M, Combes P, Eisele JH, Contet A, Blin D, Girardet P. Pulmonary function tests predict outcome after cardiac surgery. Acta Anaesthesiol Belg 1993;44:17-23.
5. Kurki TS, Kataja M. Preoperative prediction of postoperative morbidity in coronary artery bypass grafting. Ann Thorac Surg 1996;61:1740-5.
6. Samuels LE, Kaufman MS, Morris RJ, Promisloff R, Brockman SK. Coronary artery bypass grafting in patients with COPD. Chest 1998;113:878-82.
7. Spivack SD, Shinozaki T, Albertini JJ, Deane R. Preoperative prediction of postoperative respiratory outcome. Coronary artery bypass grafting. Chest 1996;109:1222-30.
8. Jacob B, Amoateng-Adjepong Y, Rasakulasuriar S, Manthous CA, Haddad R. Preoperative pulmonary function tests do not predict outcome after coronary artery bypass. Conn Med 1997;61:327-32.
9. Bando K, Sun K, Binford RS, Sharp TG. Determinants of longer duration of endotracheal intubation after adult cardiac operations. Ann Thorac Surg 1997;63:1026-33.
10. Michalopoulos A, Geroulanos S, Papadimitriou L, et al. Mild or moderate chronic obstructive pulmonary disease risk in elective coronary artery bypass grafting surgery. World J Surg 2001;25:1507-11.
11. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46.
12. American Thoracic Society. Standardization of Sprirometry, 1994 Update. Am J Respir Crit Care Med 1995;152:1107-36.
13. Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 1989;79:I3-12.
14. Dripps RD, Lamont A, Eckenhoff JE. The role of anesthesia in surgical mortality. JAMA 1961;178:261-6.
15. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
16. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128-37.
17. Peterson ED, Coombs LP, DeLong ER, Haan CK, Ferguson TB. Procedural volume as a marker of quality for CABG surgery. JAMA 2004;291:195-201.
18. Nilsson J, Algotsson L, Hoglund P, Lugrs C, Brandt J. Early mortality in coronary bypass surgery: The EuroSCORE versus The Society of Thoracic Surgeons risk algorithm. Ann Thorac Surg 2004;77:1235-9.
19. Bonacchi M, Prifti E, Giunti G, Salica A, Frati G, Sani G. Respiratory dysfunction after coronary artery bypass grafting employing bilateral internal mammary arteries: The influence of intact pleura. Eur J Cardiothorac Surg 2001;19:827-33.
20. Ishikawa S, Takahashi T, Ohtaki A, et al. Peripheral pulmonary atelectasis and oxygentation impairment following coronary artery bypass grafting. J Cardiovasc Surg (Torino) 2002;43:419-22.
21. Ng CS, Wan S, Yim AP, Arifi AA. Pulmonary dysfunction after cardiac surgery. Chest 2002;121:1269-77.
22. Légaré JF, Hirsch GM, Buth KJ, MacDougall C, Sullivan JA. Preoperative prediction of prolonged mechanical ventilation following coronary artery bypass grafting. Eur J Cardiothorac Surg 2001;20:930-6.
23. Gaynes R, Bizek B, Mowry-Hanley J, Kirsh M. Risk factors for nosocomial pneumonia after coronary artery bypass graft operations. Ann Thorac Surg 1991;51:215-8.
24. Covino E, Santise G, Di Lello F, et al. Surgical myocardial revascularization (CABG) in patients with pulmonary disease: Beating heart versus cardiopulmonary bypass. J Cardiovasc Surg (Torino) 2001;42:23-6.
25. Güler M, Kirali K, Toker ME, et al. Different CABG methods in patients with chronic obstructive pulmonary disease. Ann Thorac Surg 2001;71:152-7.
26. Ad N, Snir E, Vidne BA, Golomb E. Potential preoperative markers for the risk of developing atrial fibrillation after cardiac surgery. Semin Thorac Cardiovasc Surg 1999;11:308-13.
27. Kuralay E, Cingoz F, Kilic S, et al. Supraventricular tachyarrythmia prophylaxis after coronary artery surgery in chronic obstructive pulmonary disease patients (early amiodarone prophylaxis trial). Eur J Cardiothorac Surg 2004;25:224-30.
28. Braxton JH, Marrin CA, McGrath PD, et al. Mediastinitis and long-term survival after coronary artery bypass graft surgery. Ann Thorac Surg 2000;70:2004-7.
29. Gårdlund B, Bitkover CY, Vaage J. Postoperative mediastinitis in cardiac surgery - microbiology and pathogenesis. Eur J Cardiothorac Surg 2002;21:825-30
30. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107:1514-9.